Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1

Status

Unknown 3Terminated 2Completed 2

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Hodgkin Disease 3

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × OTHER × ABVD protocol × Clear all
NCT00736320 2020-11-04

HD16

University of Cologne

Phase 3 Unknown
1,150 enrolled
Lymphoid

Hodgkin Disease

NCT00816959 2011-07-20

Study Evaluating the Effect of R-mabHDI in Lymphocytic Predominant Hodgkin's Lymphoma

American Scitech International

Phase 3 Unknown
1,200 enrolled
Lymphoid

Hodgkin Disease

NCT00188149 2005-12-29

Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET

University Hospital Carl Gustav Carus

Phase 4 Unknown
300 enrolled
Lymphoid

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡